Recent Updates
Recently added Catalysts
PTCT Positive Sentiment

PTC Therapeutics to Participate in Upcoming Investor Conferences

Key Takeaway: PTC Therapeutics, Inc. has announced its participation in several upcoming investor conferences, including the Wells Fargo 21st Annual Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference. Executives will present key insights on the company's pipeline and strategies. The presentations will be available via live webcast and archived for future access.
Price reaction · baseline $72.69 (2026-08-26 close) · hit pre-market · clean, no other PTCT news in the window
day 0 close · peak
-1.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • PTC Therapeutics is actively engaging with investors.
  • The company is showcasing its commitment to transparency through webcasts.
  • Participation in multiple high-profile healthcare conferences highlights its growth.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
4.2%
average across 6 past catalysts
Lead asset
EPI-743
Phase 2 · Leigh Syndrome

Full Press Release Details

WARREN, N.J., Aug. 27, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

Wells Fargo 21 st Annual Healthcare Conference Thursday, Sept. 10 at 9:30 a.m. ET

2026 Cantor Global Healthcare Conference Friday, Sept. 11 at 8:35 a.m. ET

Morgan Stanley 24 th Annual Global Healthcare Conference Tuesday, Sept. 15 at 9:15 a.m. ET

The presentations will be webcast live on the Events and Presentations page under the Investor section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc. PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.

Investors: Ellen Cavaleri +1 (615) 618-8228 [email protected]

Media: Jeanine Clemente +1 (908) 912-9406 [email protected]

Frequently Asked Questions

When will PTC Therapeutics present at the conferences?

PTC Therapeutics will present at the Wells Fargo Conference on Sept. 10, Cantor Conference on Sept. 11, and Morgan Stanley Conference on Sept. 15.

How can I access the presentations?

The presentations will be webcast live and archived for 30 days on PTC's Investor section of their website.

What is the focus of PTC Therapeutics?

PTC Therapeutics is dedicated to developing medicines for rare disorders, aiming to meet unmet medical needs.

Where can I find more information about PTC Therapeutics?

More information can be found on PTC Therapeutics' official website and their social media platforms.

Last updated: Aug 27, 2026